Rossari Biotech Limited subsidiaries announce capacity expansion

The Board of Directors of Unitop Chemicals Private Limited, a material subsidiary of Rossari Biotech Limited, at their meeting held on April 24, 2025, reviewed and discussed the opportunities for growth and expansion. Further, approved the capacity expansion for the subsidiary company by 18500 MTPA in phased manner till 4th Quarter of FY 2025-26 at an outlay of Rs. 77 Crores which will funded through mix of internal accruals and debt.

This project is intended to accommodate new product lines. It aligns with market demand forecasts and enhances the competitive edge in the domestic and export markets.

The Board of Directors of Tristar Intermediates Private Limited, a material subsidiary of Rossari Biotech Limited, at their meeting held on April 24, 2025, reviewed and discussed the opportunities for growth and expansion. Further, approved the capacity expansion for the subsidiary company by adding 3600 MTPA from its existing capacity of 15000 MTPA which is running at 90% capacity utilization. The expansion will be carried out at an outlay of Rs. 20 Crores which will be funded through mix of internal accruals and debt. The new capacity is expected to be commissioned by Q4 FY 2025-26.

The rationale behind the expansion is upgradation of existing equipment's with modern technology to improve energy efficiency, product consistency, and process safety. It will also reduce maintenance costs in long-run.

Shares of Rossari Biotech Limited was last trading in BSE at Rs. 698.80 as compared to the previous close of Rs. 704.60. The total number of shares traded during the day was 11633 in over 1146 trades.

The stock hit an intraday high of Rs. 715.00 and intraday low of 684.60. The net turnover during the day was Rs. 8113172.00.

Source : Equity Bulls

Keywords

RossariBiotech INE02A801020 SpecialtyChemicals Subsidiary CapacityExpansion Capex